Press Archives

May 30, 2017

Raja Mazumder, Ph.D., at the GW School of Medicine and Health Sciences received a NIH grant to develop databases to normalize cancer genomics data.

May 25, 2017

Anelia Horvath, Ph.D., associate research professor of pharmacology & physiology, published research in the New England Journal of Medicine finding that some women with BRCA 1/2 genetic mutations also have the co-occurrence of a rare COMT genetic variant. 

May 25, 2017

Colin Young, Ph.D, published research in the Journal of Clinical Investigation Insight showing that endoplasmic reticulum stress in the brain may contribute to development of nonalcoholic fatty liver disease.

May 16, 2017

Vittorio Gallo, Ph.D., professor of pediatrics and of pharmacology and physiology, will serve as the associate dean for child health research - a newly established position within the school to enhance research relationships between GW SMHS and Children's National Health System.

May 11, 2017

Urgent Matters, Philips Blue Jay Consulting, and Schumacher Clinical Partners are now accepting submissions for the 2017 Emergency Care Innovation of the Year Award, a competitive opportunity that fosters innovation in emergency departments nationwide.

May 04, 2017

Xiaoyen Zheng, Ph.D., assistant professor of anatomy and regenerative biology, recently received a $1.7 million grant from the National Institutes of Health and National Institute of General Medical Sciences to study the underlying mechanisms of the Hedgehog receptor.

April 20, 2017

A research team at Children’s National Health System, led by Zhe Han, Ph.D., associate professor in the Center for Cancer & Immunology Research, published a report in Journal of the American Society of Nephrology about a dietary supplement that has demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies.

April 19, 2017

Brad Jones, Ph.D., assistant professor of microbiology, immunology, and tropical medicine, published research in Cell Host & Microbe finding defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV.